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Background: There are limited data on temporal trends in percutaneous coronary intervention (PCI) outcomes among older patients, particularly 
in females and patients ≥75 years of age.
Methods: We used data on PCI procedures from the Centers for Medicare & Medicaid Service’s Chronic Condition Warehouse (n=3,250,836) to 
compare patient characteristics and rates of 3-year major adverse cardiac events (MACE) defined as death, myocardial infarction (MI), or repeat 
revascularization across the balloon angioplasty (POBA) era (January 1991-September 1995), the bare metal stent (BMS) era (February 1998-April 
2003), and the drug-eluting stent (DES) era (May 2004-October 2006). The adjusted association between era and MACE was determined with Cox 
proportional hazards modeling using the POBA era as the reference. We also compared outcomes in females vs. males, and patients ≥ 75 years old 
vs. those < 75 years old.
Results: Patients undergoing PCI during the BMS and DES era were significantly older and had more medical comorbidities compared with the 
POBA era. The risk for 3-year MACE was significantly lower during the BMS and DES eras compared with the POBA era (BMS: adjusted hazard ratio 
[HR], 95% confidence interval [CI] 0.930, 0.926-0.935; DES: 0.831, 0.827-0.835). Compared with males, the adjusted risk for 3-year MACE among 
females was lower during the POBA era (HR 0.965, 95% CI 0.957-0.975), but slightly higher during the BMS and DES eras (BMS: 1.026, 1.020-
1.032; DES: 1.031, 1.023-1.039), driven primarily by a higher MI risk. Patients ≥75 years of age had higher adjusted risk for MACE compared with 
younger patients across all eras, driven by a higher risk for death and MI. The risk for revascularization was lower for both females and older patients 
across all three eras.
Conclusions: Despite its application in older and sicker Medicare beneficiaries, major adverse cardiac events have significantly improved over 
time. In the BMS and DES eras, females and older patients appear to have a higher risk for death or MI compared with males and younger patients. 
Future studies should focus on strategies to improve clinical outcomes in these high-risk subgroups as PCI technology evolves.
